BioVersys granted Fast-Track Designation from US FDA for BV100
This designation underscores the significant unmet medical need for new treatment options for patients suffering from serious infections caused by…
BEAM at work
Our advocacy work is based on analysis and reflection with our members.
Each topic is dealt with by a task force, which acts as a discussion platform and issues policy briefs.
